Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2054505rdf:typepubmed:Citationlld:pubmed
pubmed-article:2054505lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:2054505lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2054505lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:2054505lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:2054505lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2054505lifeskim:mentionsumls-concept:C0205470lld:lifeskim
pubmed-article:2054505pubmed:issue3lld:pubmed
pubmed-article:2054505pubmed:dateCreated1991-8-1lld:pubmed
pubmed-article:2054505pubmed:abstractTextThe immunoreactivity of serum samples from HIV-2 infected persons was studied by radioimmunoprecipitation assay (RIPA) in homo- and heterotypic variants. In homotypic RIPA all sera studied have precipitated the viral glycoprotein with the high molecular weight, gp170. Some samples were active for gag-gene products, p57 and p26 in homotypic RIPA. Most these samples were also active for heterotypic gag-protein of HIV-1 serotype, p55 and p24. On the other hand anti-gag reactivity of one sample was limited only by homotypic activity. Some causes of this phenomena as well as its significance for serodiagnosis of HIV infection are discussed.lld:pubmed
pubmed-article:2054505pubmed:languageruslld:pubmed
pubmed-article:2054505pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:citationSubsetIMlld:pubmed
pubmed-article:2054505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2054505pubmed:statusMEDLINElld:pubmed
pubmed-article:2054505pubmed:monthMarlld:pubmed
pubmed-article:2054505pubmed:issn0365-9615lld:pubmed
pubmed-article:2054505pubmed:authorpubmed-author:SelimovaL MLMlld:pubmed
pubmed-article:2054505pubmed:authorpubmed-author:Za?desV MVMlld:pubmed
pubmed-article:2054505pubmed:authorpubmed-author:VeselovskaiaT...lld:pubmed
pubmed-article:2054505pubmed:authorpubmed-author:KliushnikS...lld:pubmed
pubmed-article:2054505pubmed:issnTypePrintlld:pubmed
pubmed-article:2054505pubmed:volume111lld:pubmed
pubmed-article:2054505pubmed:ownerNLMlld:pubmed
pubmed-article:2054505pubmed:authorsCompleteYlld:pubmed
pubmed-article:2054505pubmed:pagination283-4lld:pubmed
pubmed-article:2054505pubmed:dateRevised2008-10-8lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:meshHeadingpubmed-meshheading:2054505-...lld:pubmed
pubmed-article:2054505pubmed:year1991lld:pubmed
pubmed-article:2054505pubmed:articleTitle[Group- and type-specific antibodies to the gag-gene protein p26 of the human immunodeficiency virus immunological type 2 in infected patients].lld:pubmed
pubmed-article:2054505pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2054505pubmed:publicationTypeEnglish Abstractlld:pubmed